-
1
-
-
84862263770
-
Diagnosis and management of chronic graft-versus-host disease
-
Dignan, F. L., Amrolia, P., Clark, A., Cornish, J., Jackson, G., Mahendra, P., Scarisbrick, J. J. et al., Diagnosis and management of chronic graft-versus-host disease. Br. J. Haematol. 2012. 158: 46-61.
-
(2012)
Br. J. Haematol.
, vol.158
, pp. 46-61
-
-
Dignan, F.L.1
Amrolia, P.2
Clark, A.3
Cornish, J.4
Jackson, G.5
Mahendra, P.6
Scarisbrick, J.J.7
-
2
-
-
79955975797
-
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
-
Pidala, J., Kurland, B., Chai, X., Majhail, N., Weisdorf, D. J., Pavletic, S., Cutler, C. et al., Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011. 117: 4651-4657.
-
(2011)
Blood
, vol.117
, pp. 4651-4657
-
-
Pidala, J.1
Kurland, B.2
Chai, X.3
Majhail, N.4
Weisdorf, D.J.5
Pavletic, S.6
Cutler, C.7
-
3
-
-
84855613742
-
Novel treatment concepts for graft-versus-host disease
-
Wolf, D., von Lilienfeld-Toal, M., Wolf, A. M., Schleuning, M., von Bergwelt-Baildon, M., Held, S. A. E. and Brossart, P., Novel treatment concepts for graft-versus-host disease. Blood 2012. 119: 16-25.
-
(2012)
Blood
, vol.119
, pp. 16-25
-
-
Wolf, D.1
von Lilienfeld-Toal, M.2
Wolf, A.M.3
Schleuning, M.4
von Bergwelt-Baildon, M.5
Held, S.A.E.6
Brossart, P.7
-
4
-
-
79953123445
-
Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new
-
Coghill, J. M., Sarantopoulos, S., Moran, T. P., Murphy, W. J., Blazar, B. R. and Serody, J. S., Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood 2011. 117: 3268-3276.
-
(2011)
Blood
, vol.117
, pp. 3268-3276
-
-
Coghill, J.M.1
Sarantopoulos, S.2
Moran, T.P.3
Murphy, W.J.4
Blazar, B.R.5
Serody, J.S.6
-
5
-
-
61949463911
-
IL-17 and Th17 Cells
-
Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009. 27: 485-517.
-
(2009)
Annu. Rev. Immunol.
, vol.27
, pp. 485-517
-
-
Korn, T.1
Bettelli, E.2
Oukka, M.3
Kuchroo, V.K.4
-
6
-
-
52649136967
-
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease
-
Yi, T., Zhao, D., Lin, C. L., Zhang, C., Chen, Y., Todorov, I., LeBon, T. et al., Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 2008. 112: 2101-2110.
-
(2008)
Blood
, vol.112
, pp. 2101-2110
-
-
Yi, T.1
Zhao, D.2
Lin, C.L.3
Zhang, C.4
Chen, Y.5
Todorov, I.6
LeBon, T.7
-
7
-
-
73349105621
-
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation
-
Dander, E., Balduzzi, A., Zappa, G., Lucchini, G., Perseghin, P., Andre, V., Todisco, E. et al., Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009. 88: 1261-1272.
-
(2009)
Transplantation
, vol.88
, pp. 1261-1272
-
-
Dander, E.1
Balduzzi, A.2
Zappa, G.3
Lucchini, G.4
Perseghin, P.5
Andre, V.6
Todisco, E.7
-
8
-
-
78851472301
-
IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation
-
Zhao, X. Y., Xu, L. L., Lu, S. Y. and Huang, X. J., IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation. Eur. J. Immunol. 2011. 41: 514-526.
-
(2011)
Eur. J. Immunol.
, vol.41
, pp. 514-526
-
-
Zhao, X.Y.1
Xu, L.L.2
Lu, S.Y.3
Huang, X.J.4
-
9
-
-
84862908181
-
Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17
-
Nishimori, H., Maeda, Y., Teshima, T., Sugiyama, H., Kobayashi, K., Yamasuji, Y., Kadohisa, S. et al., Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17. Blood 2012. 119: 285-295.
-
(2012)
Blood
, vol.119
, pp. 285-295
-
-
Nishimori, H.1
Maeda, Y.2
Teshima, T.3
Sugiyama, H.4
Kobayashi, K.5
Yamasuji, Y.6
Kadohisa, S.7
-
10
-
-
72649088089
-
Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease
-
Chen, X., Das, R., Komorowski, R., van Snick, J., Uyttenhove, C. and Drobyski, W. R., Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease. Biol. Blood Marrow Transpl. 2010. 16: 123-128.
-
(2010)
Biol. Blood Marrow Transpl.
, vol.16
, pp. 123-128
-
-
Chen, X.1
Das, R.2
Komorowski, R.3
van Snick, J.4
Uyttenhove, C.5
Drobyski, W.R.6
-
11
-
-
77956538770
-
Th17/Treg ratio in human graft-versus-host disease
-
Ratajczak, P., Janin, A., Peffault de Latour, R., Leboeuf, C., Desveaux, A., Keyvanfar, K., Robin, M. et al., Th17/Treg ratio in human graft-versus-host disease. Blood 2010. 116: 1165-1171.
-
(2010)
Blood
, vol.116
, pp. 1165-1171
-
-
Ratajczak, P.1
Janin, A.2
Peffault de Latour, R.3
Leboeuf, C.4
Desveaux, A.5
Keyvanfar, K.6
Robin, M.7
-
12
-
-
34547232503
-
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells
-
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T. B., Oukka, M. et al., IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007. 448: 484-487.
-
(2007)
Nature
, vol.448
, pp. 484-487
-
-
Korn, T.1
Bettelli, E.2
Gao, W.3
Awasthi, A.4
Jager, A.5
Strom, T.B.6
Oukka, M.7
-
13
-
-
77950599836
-
IL-21 is critical for GVHD in a mouse model
-
Meguro, A., Ozaki, K., Oh, I., Hatanaka, K., Matsu, H., Tatara, R., Sato, K. et al., IL-21 is critical for GVHD in a mouse model. Bone Marrow Transpl. 2010. 45: 723-729.
-
(2010)
Bone Marrow Transpl.
, vol.45
, pp. 723-729
-
-
Meguro, A.1
Ozaki, K.2
Oh, I.3
Hatanaka, K.4
Matsu, H.5
Tatara, R.6
Sato, K.7
-
14
-
-
73949116753
-
IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation
-
Bucher, C., Koch, L., Vogtenhuber, C., Goren, E., Munger, M., Panoskaltsis-Mortari, A., Sivakumar, P. et al., IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation. Blood 2009. 114: 5375-5384.
-
(2009)
Blood
, vol.114
, pp. 5375-5384
-
-
Bucher, C.1
Koch, L.2
Vogtenhuber, C.3
Goren, E.4
Munger, M.5
Panoskaltsis-Mortari, A.6
Sivakumar, P.7
-
15
-
-
84862909139
-
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes
-
Hippen, K. L., Bucher, C., Schirm, D. K., Bearl, A. M., Brender, T., Mink, K. A., Waggie, K. S. et al., Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood 2012. 119: 619-628.
-
(2012)
Blood
, vol.119
, pp. 619-628
-
-
Hippen, K.L.1
Bucher, C.2
Schirm, D.K.3
Bearl, A.M.4
Brender, T.5
Mink, K.A.6
Waggie, K.S.7
-
16
-
-
0018973048
-
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
-
Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., Hackman, R. et al., Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am. J. Med. 1980. 69: 204-217.
-
(1980)
Am. J. Med.
, vol.69
, pp. 204-217
-
-
Shulman, H.M.1
Sullivan, K.M.2
Weiden, P.L.3
McDonald, G.B.4
Striker, G.E.5
Sale, G.E.6
Hackman, R.7
-
17
-
-
44949231424
-
Analyzing real-time PCR data by the comparative C(T) method
-
Schmittgen, T. D. and Livak, K. J., Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008. 3: 1101-1108.
-
(2008)
Nat. Protoc.
, vol.3
, pp. 1101-1108
-
-
Schmittgen, T.D.1
Livak, K.J.2
-
18
-
-
28744444180
-
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
-
Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., Martin, P. et al., National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol. Blood Marrow Transpl. 2005. 11: 945-956.
-
(2005)
Biol. Blood Marrow Transpl.
, vol.11
, pp. 945-956
-
-
Filipovich, A.H.1
Weisdorf, D.2
Pavletic, S.3
Socie, G.4
Wingard, J.R.5
Lee, S.J.6
Martin, P.7
-
19
-
-
84855406581
-
The IL-17 differentiation pathway and its role in transplant outcome
-
Serody, J. S. and Hill, G. R., The IL-17 differentiation pathway and its role in transplant outcome. Biol. Blood Marrow Transpl. 2012. 18: S56-S61.
-
(2012)
Biol. Blood Marrow Transpl.
, vol.18
-
-
Serody, J.S.1
Hill, G.R.2
-
20
-
-
70449730679
-
+ T-cell repertoire is biased to a Th17 response and the frequency is inversely related to the number of HLA class II mismatches
-
+ T-cell repertoire is biased to a Th17 response and the frequency is inversely related to the number of HLA class II mismatches. Blood 2009. 114: 3947-3955.
-
(2009)
Blood
, vol.114
, pp. 3947-3955
-
-
Litjens, N.H.1
van de Wetering, J.2
van Besouw, N.M.3
Betjes, M.G.4
-
21
-
-
81355148789
-
Deciphering the role of Th17 cells in human disease
-
Wilke, C. M., Bishop, K., Fox, D. and Zou, W., Deciphering the role of Th17 cells in human disease. Trends Immunol. 2011. 32: 603-611.
-
(2011)
Trends Immunol.
, vol.32
, pp. 603-611
-
-
Wilke, C.M.1
Bishop, K.2
Fox, D.3
Zou, W.4
-
22
-
-
33646577466
-
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
-
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
-
(2006)
Nature
, vol.441
, pp. 235-238
-
-
Bettelli, E.1
Carrier, Y.2
Gao, W.3
Korn, T.4
Strom, T.B.5
Oukka, M.6
Weiner, H.L.7
-
23
-
-
34247602156
-
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation
-
Huang, X.-J., Liu, D.-H., Liu, K.-Y., Xu, L.-P., Chen, H. and Han, W., Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica 2007. 92: 414-417.
-
(2007)
Haematologica
, vol.92
, pp. 414-417
-
-
Huang, X.-J.1
Liu, D.-H.2
Liu, K.-Y.3
Xu, L.-P.4
Chen, H.5
Han, W.6
-
24
-
-
84864879416
-
Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis
-
Wang, Y., Liu, D. H., Xu, L. P., Liu, K. Y., Chen, H., Zhang, X. H., Chen, Y. H. et al., Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis. Bone Marrow Transpl. 2011. 47: 1099-1104.
-
(2011)
Bone Marrow Transpl.
, vol.47
, pp. 1099-1104
-
-
Wang, Y.1
Liu, D.H.2
Xu, L.P.3
Liu, K.Y.4
Chen, H.5
Zhang, X.H.6
Chen, Y.H.7
-
25
-
-
84870697866
-
Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors
-
Yan, C. H., Liu, D. H., Xu, L. P., Liu, K. Y., Zhao, T., Wang, Y., Chen, H. et al., Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors. Clin. Transplant. 2012. 26: 868-876.
-
(2012)
Clin. Transplant.
, vol.26
, pp. 868-876
-
-
Yan, C.H.1
Liu, D.H.2
Xu, L.P.3
Liu, K.Y.4
Zhao, T.5
Wang, Y.6
Chen, H.7
-
26
-
-
20344396399
-
A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF) primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts
-
Jun, H. X., Jun, C. Y. and Yu, Z. X., A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF) primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts. Haematologica 2005. 90: 715-716.
-
(2005)
Haematologica
, vol.90
, pp. 715-716
-
-
Jun, H.X.1
Jun, C.Y.2
Yu, Z.X.3
-
27
-
-
10444239214
-
In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor
-
Jun, H. X., Jun, C. Y. and Yu, Z. X., In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 2004. 89: 1517-1524.
-
(2004)
Haematologica
, vol.89
, pp. 1517-1524
-
-
Jun, H.X.1
Jun, C.Y.2
Yu, Z.X.3
-
28
-
-
68649087586
-
Expression profiles of adhesion molecules on naive T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor
-
Chang, Y. J., Zhao, X. Y., Huo, M. R. and Huang, X. J., Expression profiles of adhesion molecules on naive T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor. Transpl. Immunol. 2009. 21: 228-233.
-
(2009)
Transpl. Immunol.
, vol.21
, pp. 228-233
-
-
Chang, Y.J.1
Zhao, X.Y.2
Huo, M.R.3
Huang, X.J.4
-
29
-
-
0034597789
-
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
-
Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J. et al., Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000. 408: 57-63.
-
(2000)
Nature
, vol.408
, pp. 57-63
-
-
Parrish-Novak, J.1
Dillon, S.R.2
Nelson, A.3
Hammond, A.4
Sprecher, C.5
Gross, J.A.6
Johnston, J.7
-
30
-
-
34547204946
-
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells
-
Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K. et al., Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007. 448: 480-483.
-
(2007)
Nature
, vol.448
, pp. 480-483
-
-
Nurieva, R.1
Yang, X.O.2
Martinez, G.3
Zhang, Y.4
Panopoulos, A.D.5
Ma, L.6
Schluns, K.7
-
31
-
-
44549084734
-
Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses
-
Monteleone, G., Pallone, F. and MacDonald, T. T., Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses. Trends Immunol. 2008. 29: 290-294.
-
(2008)
Trends Immunol.
, vol.29
, pp. 290-294
-
-
Monteleone, G.1
Pallone, F.2
MacDonald, T.T.3
-
32
-
-
84867505772
-
Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning
-
Weisdorf, D., Zhang, M. J., Arora, M., Horowitz, M. M., Rizzo, J. D. and Eapen, M., Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biol. Blood Marrow Transpl. 2012. 18: 1727-1733.
-
(2012)
Biol. Blood Marrow Transpl.
, vol.18
, pp. 1727-1733
-
-
Weisdorf, D.1
Zhang, M.J.2
Arora, M.3
Horowitz, M.M.4
Rizzo, J.D.5
Eapen, M.6
-
33
-
-
84871228768
-
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation
-
Baron, F., Labopin, M., Niederwieser, D., Vigouroux, S., Cornelissen, J. J., Malm, C., Vindelov, L. L. et al., Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation. Leukemia 2012. 26: 2462-2468.
-
(2012)
Leukemia
, vol.26
, pp. 2462-2468
-
-
Baron, F.1
Labopin, M.2
Niederwieser, D.3
Vigouroux, S.4
Cornelissen, J.J.5
Malm, C.6
Vindelov, L.L.7
-
34
-
-
84863508785
-
Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease
-
Rangarajan, H., Yassai, M., Subramanian, H., Komorowski, R., Whitaker, M., Gorski, J. and Drobyski, W. R., Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease. Blood 2012. 119: 6354-6364.
-
(2012)
Blood
, vol.119
, pp. 6354-6364
-
-
Rangarajan, H.1
Yassai, M.2
Subramanian, H.3
Komorowski, R.4
Whitaker, M.5
Gorski, J.6
Drobyski, W.R.7
-
35
-
-
0031737114
-
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis
-
Carlens, S., Ringden, O., Remberger, M., Lonnqvist, B., Hagglund, H., Klaesson, S., Mattsson, J. et al., Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transpl. 1998. 22: 755-761.
-
(1998)
Bone Marrow Transpl.
, vol.22
, pp. 755-761
-
-
Carlens, S.1
Ringden, O.2
Remberger, M.3
Lonnqvist, B.4
Hagglund, H.5
Klaesson, S.6
Mattsson, J.7
-
36
-
-
80054113450
-
Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease
-
Martires, K. J., Baird, K., Steinberg, S. M., Grkovic, L., Joe, G. O., Williams, K. M., Mitchell, S. A. et al., Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood 2011. 118: 4250-4257.
-
(2011)
Blood
, vol.118
, pp. 4250-4257
-
-
Martires, K.J.1
Baird, K.2
Steinberg, S.M.3
Grkovic, L.4
Joe, G.O.5
Williams, K.M.6
Mitchell, S.A.7
-
37
-
-
33746936705
-
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
-
Huang, X. J., Liu, D. H., Liu, K. Y., Xu, L. P., Chen, H., Han, W., Chen, Y. H. et al., Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transpl. 2006. 38: 291-297.
-
(2006)
Bone Marrow Transpl.
, vol.38
, pp. 291-297
-
-
Huang, X.J.1
Liu, D.H.2
Liu, K.Y.3
Xu, L.P.4
Chen, H.5
Han, W.6
Chen, Y.H.7
-
38
-
-
33645734218
-
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
-
Lu, D. P., Dong, L., Wu, T., Huang, X. J., Zhang, M. J., Han, W., Chen, H. et al., Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006. 107: 3065-3073.
-
(2006)
Blood
, vol.107
, pp. 3065-3073
-
-
Lu, D.P.1
Dong, L.2
Wu, T.3
Huang, X.J.4
Zhang, M.J.5
Han, W.6
Chen, H.7
-
39
-
-
84862543020
-
The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission
-
Huang, X. J., Zhu, H. H., Chang, Y. J., Xu, L. P., Liu, D. H., Zhang, X. H., Jiang, B. et al., The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission. Blood 2012. 119: 5584-5590.
-
(2012)
Blood
, vol.119
, pp. 5584-5590
-
-
Huang, X.J.1
Zhu, H.H.2
Chang, Y.J.3
Xu, L.P.4
Liu, D.H.5
Zhang, X.H.6
Jiang, B.7
-
40
-
-
79953102786
-
Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase
-
Jiang, Q., Xu, L. P., Liu, D. H., Liu, K. Y., Chen, S. S., Jiang, B., Jiang, H. et al., Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase. Blood 2011. 117: 3032-3040.
-
(2011)
Blood
, vol.117
, pp. 3032-3040
-
-
Jiang, Q.1
Xu, L.P.2
Liu, D.H.3
Liu, K.Y.4
Chen, S.S.5
Jiang, B.6
Jiang, H.7
-
41
-
-
84859464436
-
Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT
-
Zhao, X. S., Jin, S., Zhu, H. H., Xu, L. P., Liu, D. H., Chen, H., Liu, K. Y. et al., Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT. Bone Marrow Transpl. 2012. 47: 499-507.
-
(2012)
Bone Marrow Transpl.
, vol.47
, pp. 499-507
-
-
Zhao, X.S.1
Jin, S.2
Zhu, H.H.3
Xu, L.P.4
Liu, D.H.5
Chen, H.6
Liu, K.Y.7
-
42
-
-
84857365039
-
Monitoring MRD with flow cytometry: an effective method to predict relapse for all patients after allogeneic hematopoietic stem cell transplantation
-
Zhao, X. S., Liu, Y. R., Zhu, H. H., Xu, L. P., Liu, D. H., Liu, K. Y. and Huang, X. J., Monitoring MRD with flow cytometry: an effective method to predict relapse for all patients after allogeneic hematopoietic stem cell transplantation. Ann. Hematol. 2012. 91: 183-192.
-
(2012)
Ann. Hematol.
, vol.91
, pp. 183-192
-
-
Zhao, X.S.1
Liu, Y.R.2
Zhu, H.H.3
Xu, L.P.4
Liu, D.H.5
Liu, K.Y.6
Huang, X.J.7
-
43
-
-
84859572115
-
Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
-
Yan, C. H., Liu, D. H., Liu, K. Y., Xu, L. P., Liu, Y. R., Chen, H., Han, W. et al., Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood 2012. 119: 3256-3262.
-
(2012)
Blood
, vol.119
, pp. 3256-3262
-
-
Yan, C.H.1
Liu, D.H.2
Liu, K.Y.3
Xu, L.P.4
Liu, Y.R.5
Chen, H.6
Han, W.7
-
44
-
-
84864946676
-
Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study
-
Wang, Y., Liu, D. H., Fan, Z. P., Sun, J., Wu, X. J., Ma, X., Xu, L. P. et al., Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study. Clin. Transpl. 2012. 26: 635-643.
-
(2012)
Clin. Transpl.
, vol.26
, pp. 635-643
-
-
Wang, Y.1
Liu, D.H.2
Fan, Z.P.3
Sun, J.4
Wu, X.J.5
Ma, X.6
Xu, L.P.7
-
45
-
-
0016860720
-
Bone-marrow transplantation (second of two parts)
-
Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, L., Neiman, P. E., Lerner, K. G. et al., Bone-marrow transplantation (second of two parts). N. Engl. J. Med. 1975. 292: 895-902.
-
(1975)
N. Engl. J. Med.
, vol.292
, pp. 895-902
-
-
Thomas, E.D.1
Storb, R.2
Clift, R.A.3
Fefer, A.4
Johnson, L.5
Neiman, P.E.6
Lerner, K.G.7
|